Disease Overview：Corpus gastritis（CG）
Gastritis of the gastric body—also termed corpus gastritis—is a localized inflammatory condition affecting the fundus and body of the stomach, distinct from antral or pangastritis. It commonly arises from chronic Helicobacter pylori infection, autoimmune mechanisms (e.g., autoimmune gastritis with anti-parietal cell antibodies), long-term NSAID use, or bile reflux. Patients may present with epigastric discomfort, early satiety, nausea, or remain asymptomatic until complications such as atrophic gastritis, intestinal metaplasia, or vitamin B12 deficiency emerge. Diagnosis relies on high-definition upper gastrointestinal endoscopy with targeted biopsies, histopathological assessment (including Sydney System grading), and ancillary tests like serum pepsinogen I/II ratio and gastrin-17 levels to evaluate gastric mucosal function and atrophy risk. Accurate subtyping is critical, as corpus-predominant inflammation carries higher neoplastic potential due to oxyntic gland loss and hypochlorhydria.
China offers distinct advantages for managing corpus gastritis: leading gastroenterology centers—such as those affiliated with Peking Union Medical College Hospital and Zhongshan Hospital (Fudan University)—employ AI-enhanced endoscopic imaging (e.g., linked-color imaging and magnification-NBI) for early detection of mucosal atrophy and dysplasia. Multidisciplinary teams integrate H. pylori eradication regimens tailored to regional resistance patterns, proton-pump inhibitor optimization, and longitudinal surveillance protocols validated in large cohort studies. Treatment outcomes align with international benchmarks, with >92% H. pylori eradication rates in first-line therapy and robust 5-year follow-up data demonstrating reduced progression to premalignant changes. Costs remain significantly lower than in the US, UK, or Germany—endoscopy with biopsy and comprehensive serologic profiling typically costs under USD 800, inclusive of physician consultation and pathology analysis.
As a dedicated medical tourism agency, we facilitate seamless access to these specialized services for international patients: vetting JCI-accredited hospitals, coordinating appointments with bilingual gastroenterologists, providing itemized, transparent pricing upfront, and offering end-to-end support—from visa assistance and accommodation to post-procedure telehealth follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Gastric Body Inflammation (Gastritis)
Non-Surgical / Conservative Management
*Target Criteria:* Mild-to-moderate endoscopic/histologic gastritis without bleeding, strictures, or malignancy; H. pylori–positive or NSAID-induced cases.
- •Diagnostic Workup (Pre-Treatment)
- *H. pylori* testing (urea breath test or stool antigen): $35–$65 - Complete blood count + liver/kidney function panel: $45–$75 - Serum pepsinogen I/II + gastrin-17 (for atrophic risk stratification): $110–$160
- •First-Line Pharmacotherapy (4–8 weeks)
- *H. pylori* eradication (quadruple therapy: bismuth + tetracycline + metronidazole + PPI × 10 days): $95–$145/course - Sucralfate suspension (mucosal protectant): $22–$38/month - Vitamin B12 supplementation (if confirmed deficiency): $8–$15/month
Surgical / Procedural Interventions
*Eligibility Criteria:* Refractory bleeding uncontrolled by endoscopic therapy; severe atrophy/metaplasia with high-grade dysplasia confirmed on ≥2 biopsies; suspicion of early gastric adenocarcinoma in gastric body.
- •Preoperative Evaluation
- Cardiopulmonary assessment (ECG + echocardiogram + pulmonary function if >65 yrs): $130–$210
- •Interventional Procedures
- Endoscopic submucosal dissection (ESD) for larger lesions (>2 cm) or suspected intramucosal cancer: $3,200–$4,100 - Laparoscopic partial gastrectomy (for multifocal high-grade dysplasia or T1a cancer): $6,900–$8,700
Special / Complex Condition Management
- •Autoimmune Gastritis with Pernicious Anemia: Lifelong parenteral B12 (cyanocobalamin 1,000 µg IM monthly): $24–$40/injection; annual endoscopic surveillance: $280–$420
- •Refractory Erosive Gastritis with Chronic Bleeding: Argon plasma coagulation (APC) during endoscopy: $380–$520/session
- •Post-Gastrectomy Gastritis (Stump Gastritis): High-dose PPI + bile acid sequestrant (cholestyramine): $55–$90/month
Quick Selection Guide
- •Young adult (<45), H. pylori+, mild symptoms: Start with *H. pylori* eradication + 4-week PPI (Total upfront: $130–$210)
- •Elderly (>70), comorbid CKD/diabetes, moderate atrophy: Avoid NSAIDs + low-dose PPI + B12 monitoring (Annual cost: $180–$320)
- •Severe erosions + recurrent bleeding: Urgent endoscopy + APC (Single-session cost: $380–$520)
- •Confirmed high-grade dysplasia: ESD preferred over surgery for localized lesions (Cost differential vs. gastrectomy: ~$3,700–$5,900 savings)
- •Budget-constrained patient (<$200 total): Prioritize endoscopy + *H. pylori* test + generic PPI (Minimum viable package: $320–$485, but excludes treatment if positive)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Corpus gastritis Medical Vacation Packages
Curated transparent all-inclusive packages combining Corpus gastritis treatment with China top medical destinations:
